Thailand looks for chip financial investments amidst US-China profession battle - The Tamesis

Thailand’s semiconductor approach intends to make a $15 billion financial investment by 2029.

Post Views: 78

Tags

Related Posts

Vietnam leader To Lam seeks China-style powers at party conclave

January 20, 2026

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 20, 2026

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 19, 2026

The Tamesis

Leave a Reply Cancel reply

Latest from Blog

SFMOMA Acquires 85 Artworks by Nan Goldin, Ruth Asawa, and Others

A Different Way of Seeing the Burgundy Region? From the Water

Ahead of the 2026 Oscar Nominations, Here’s What Vogue Editors Hope Will Earn a Best-Costumes Nod

The Bride Wore an Archival Ralph Lauren Dress—in Bright Yellow—for Her Menorca Wedding

Feng Chen Wang Fall 2026 Menswear Collection

Philadelphia Art Museum Director Says Board Won’t Need ‘Restructuring’

Inside Valentino Garavani’s Many Glamorous Homes, as Seen in Vogue

Giuseppe Di Morabito Pre-Fall 2026 Collection

Egonlab Fall 2026 Menswear Collection

China Urges Europe to Reassess its Dependence on the US

Related Posts

Vietnam leader To Lam seeks China-style powers at party conclave

January 20, 2026

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 20, 2026

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 19, 2026

Don't Miss

Vietnam leader To Lam seeks China-style powers at party conclave

This handout photo taken and released

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

Singapore’s biopharmaceutical industry is expected to